Skip to main content

Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.

Publication ,  Conference
Li, J; Beaver, J; Bitting, RL; Gregory, S; Armstrong, AJ
Published in: Journal of Clinical Oncology
May 20, 2015

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

5042 / 5042

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Li, J., Beaver, J., Bitting, R. L., Gregory, S., & Armstrong, A. J. (2015). Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy. In Journal of Clinical Oncology (Vol. 33, pp. 5042–5042). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.5042
Li, Jing, Joshua Beaver, Rhonda Lynn Bitting, Simon Gregory, and Andrew J. Armstrong. “Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.” In Journal of Clinical Oncology, 33:5042–5042. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.5042.
Li J, Beaver J, Bitting RL, Gregory S, Armstrong AJ. Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 5042–5042.
Li, Jing, et al. “Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. 5042–5042. Crossref, doi:10.1200/jco.2015.33.15_suppl.5042.
Li J, Beaver J, Bitting RL, Gregory S, Armstrong AJ. Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. 5042–5042.

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

May 20, 2015

Volume

33

Issue

15_suppl

Start / End Page

5042 / 5042

Publisher

American Society of Clinical Oncology (ASCO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences